| NCT ID | NCT05014971 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Lewy Body Dementia With Behavioral Disturbance |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2022-02-28 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2022-02-28 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Eligibility Criteria
Participant with Lewy Body Dementia (LBD) Inclusion Criteria: * LBD diagnosis by a dementia or movement disorders specialist * Clinician-determined mild-moderate dementia severity * Internet access with a Zoom-compatible device * Caregiver who resides in the patient's home and is willing to participate * Fluency in English
Contact & Investigator
Bhavana Patel, DO
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT05014971 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Lewy Body Dementia With Behavioral Disturbance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05014971 currently recruiting?
Yes, NCT05014971 is actively recruiting participants. Contact the research team at bhavana.patel@neurology.ufl.edu for enrollment information.
Where is the NCT05014971 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT05014971 clinical trial?
NCT05014971 is sponsored by University of Florida. The principal investigator is Bhavana Patel, DO at University of Florida. The trial plans to enroll 106 participants.